CARPENTER ROBERT J 4

What Happened

• Robert J. Carpenter, a director of Immuneering Corp (IMRX), received a grant (reported as a derivative acquisition) of 33,350 shares/options on June 11, 2026. The filing lists the acquisition price as $0.00, indicating an awarded equity grant rather than an open‑market purchase. No cash proceeds or sales were reported.

Key Details

• Transaction date: 2026-06-11; transaction type: A (award/grant of derivative securities).
• Reported amount: 33,350 shares (derivative); price reported: $0.00.
• Shares owned after the transaction: not disclosed in the filing.
• Footnote: the award vests in equal monthly installments over a one‑year period beginning July 11, 2026, and will be fully vested on June 11, 2027 (or at the 2027 annual meeting, if earlier).
• Timeliness: filing date equals transaction date (no late filing indicated).

Context

• This is an equity compensation grant (derivative award) that vests over time; it is not an immediate purchase or sale and does not by itself represent a market buy or sell signal. Such grants are commonly part of director compensation and should be interpreted as a compensation event rather than a direct expression of trading intent.